Esomeprazole and omeprazole could possibly boost the serum concentrations of benzodiazepines (through CYP2C19 inhibition) bringing about improved adverse effects such as drowsiness, although the clinical relevance is lower for most people – monitor the affected person for adverse effects (e.If affected individual are unable to resume their usual